GENEVA, Oct. 20 -- BONUM THERAPEUTICS, INC. (1150 Eastlake Ave E, Suite 1100Seattle, Washington 98109) filed a patent application (PCT/US2025/023482) for "LAG-3-REGULATABLE IL-2 RECEPTOR AGONISTS" on Apr 07, 2025. With publication no. WO/2025/217058, the details related to the patent application was published on Oct 16, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MULLIGAN, John Thomas (1150 Eastlake Ave E, Suite 1100Seattle, Washington 98109), OKADA, Shannon Lee (1150 Eastlake Ave E, Suite 1100Seattle, Washington 98109), KILLEBREW, Justin Richard (1150 Eastlake Ave E, Suite 1100Seattle, ...